CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 35 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $35,000 | -35.2% | 150,015 | 0.0% | 0.00% | – |
Q4 2017 | $54,000 | -30.8% | 150,015 | -0.0% | 0.00% | – |
Q3 2017 | $78,000 | -10.3% | 150,026 | -0.0% | 0.00% | – |
Q2 2017 | $87,000 | -67.4% | 150,046 | -0.3% | 0.00% | – |
Q1 2017 | $267,000 | +42.0% | 150,449 | -3.9% | 0.00% | – |
Q4 2016 | $188,000 | +208.2% | 156,560 | +1195.7% | 0.00% | – |
Q2 2015 | $61,000 | – | 12,083 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vantage Investment Advisors, LLC | 143 | $0 | 0.00% |